
Utah's ALS Clinic Advances Care with New Gene Therapy
The only multidisciplinary ALS clinic in the Mountain West now offers groundbreaking gene therapy for patients with genetic forms of the disease. University of Utah Health's team brings together 10+ specialists in one visit, making life easier for the 30,000 Americans living with ALS.
Living with ALS just got a little less lonely in the Mountain West, thanks to a clinic that's rewriting how patients access cutting-edge care and compassionate support.
University of Utah Health's Motor Neuron Disease/ALS Clinic has become the region's only one-stop center where patients can see neurologists, physical therapists, dietitians, and genetic counselors all in one appointment. For people whose muscles grow weaker by the day, eliminating the burden of multiple trips to different specialists is itself a victory.
The clinic recently started offering gene therapy infusions for the 20% of ALS patients whose disease stems from proven genetic mutations. The treatment involves a series of injections into the spine, targeting the root cause rather than just symptoms.
"There is no cure for ALS yet, but treatments can help people live more comfortably and keep their independence as long as possible," says Cassie Kuhn, a nurse practitioner specializing in neuromuscular disorders at the clinic. The team creates personalized care plans that address everything from mobility challenges to breathing support to nutrition.

About 30,000 people across the United States are living with ALS, a progressive disease that attacks nerve cells controlling voluntary muscles. Early symptoms like tripping more often or slurred speech can seem minor, but they signal the start of a life-changing journey.
The Ripple Effect
The clinic's impact extends far beyond individual patient visits. University of Utah Health actively participates in the HEALEY ALS Platform Trial, which tests multiple drugs simultaneously at 80 sites nationwide, dramatically speeding up the search for effective treatments.
Researchers at the clinic also contribute to the All-ALS Consortium, collecting biomarkers that help scientists worldwide understand how the disease progresses. Every data point gathered could be the key that unlocks tomorrow's breakthrough.
The multidisciplinary approach means families don't navigate this journey alone. Social workers, case managers, and genetic counselors walk alongside patients and caregivers, addressing emotional needs and practical challenges with equal care.
From physical therapy that preserves mobility longer to speech therapy that keeps communication possible, each specialist adds another tool to help patients maintain their quality of life. When breathing becomes difficult, respiratory therapists step in with support options.
The combination of today's best treatments with tomorrow's most promising research creates something invaluable: hope grounded in real science and genuine compassion.
Based on reporting by Google News - New Treatment
This story was written by BrightWire based on verified news reports.
Spread the positivity!
Share this good news with someone who needs it


